Fr. 239.00

Therapeutic Hypothermia

Anglais · Livre Relié

Expédition généralement dans un délai de 6 à 7 semaines

Description

En savoir plus

Samuel A. Tisherman, MD', Fritz Sterz, MD~ '~niversit~ of Pittsburgh, Pittsburgh, PA, USA 2~edical University of Vienna, Vienna, Austria The use of hypothermia for a variety of therapeutic purposes has a long and erratic history. Hippocrates recommended the use of topical cooling to stop bleeding. Fay used cooling of the extremities for patients with tumors in the 1930s. It wasn't until the 1950s, when the effects of hypothermia on systemic oxygen metabolism became better defined, that systemic hypothermia became a commonly used modality, particularly for cardiac surgery. Hypothermia was used for protection (treatment before the insult) and preservation (treatment during the insult) of the heart and entire organism during planned operative ischemia. Shortly thereafter, attempts were made to use hypothermia for resuscitation (treatment after the insult) from cardiac arrest and for management of head trauma. At that time, it was felt that moderate hypothermia (28-32OC) was needed. This was difficult to achieve and manage. Multiple complications were noted. Consequently, therapeutic, resuscitative hypothermia lay dormant for many years while mild (32-35°C) to moderate hypothermia became common for many cardiothoracic and neurosurgical procedures. In the early 1990s, it was found that mild hypothermia, even after cardiac arrest, had benefit for the brain. Similar results were found with head trauma. This lead to a burst of enthusiasm for research into resuscitative hypothermia for a variety of insults, most of which have tissue ischemia as a major component.

Table des matières

Global Brain Ischemia: Animal Studies.- Global Cerebral Ischemia: Clinical Studies.- Focal Cerebral Ischemia: Mechanisms.- Focal Cerebral Ischemia: Clinical Studies.- Traumatic Brain Injury: Laboratory Studies.- Traumatic Brain Injury: Clinical Studies.- Spinal Cord Ischemia and Trauma.- Asphyxia.- Neonatal Asphyxia.- Hemorrhagic Shock and Exsanguination Cardiac Arrest.- Adult Respiratory Distress Syndrome and Sepsis.- Liver Failure and Intracerebral Hypertension.- Myocardial Ischemia and Infarction.- Cooling Methods.- Detrimental Effects of Hypothermia.- Future Directions.

Résumé

Samuel A. Tisherman, MD', Fritz Sterz, MD~ '~niversit~ of Pittsburgh, Pittsburgh, PA, USA 2~edical University of Vienna, Vienna, Austria The use of hypothermia for a variety of therapeutic purposes has a long and erratic history. Hippocrates recommended the use of topical cooling to stop bleeding. Fay used cooling of the extremities for patients with tumors in the 1930s. It wasn't until the 1950s, when the effects of hypothermia on systemic oxygen metabolism became better defined, that systemic hypothermia became a commonly used modality, particularly for cardiac surgery. Hypothermia was used for protection (treatment before the insult) and preservation (treatment during the insult) of the heart and entire organism during planned operative ischemia. Shortly thereafter, attempts were made to use hypothermia for resuscitation (treatment after the insult) from cardiac arrest and for management of head trauma. At that time, it was felt that moderate hypothermia (28-32OC) was needed. This was difficult to achieve and manage. Multiple complications were noted. Consequently, therapeutic, resuscitative hypothermia lay dormant for many years while mild (32-35°C) to moderate hypothermia became common for many cardiothoracic and neurosurgical procedures. In the early 1990s, it was found that mild hypothermia, even after cardiac arrest, had benefit for the brain. Similar results were found with head trauma. This lead to a burst of enthusiasm for research into resuscitative hypothermia for a variety of insults, most of which have tissue ischemia as a major component.

Détails du produit

Collaboration H Sterz (Editeur), H Sterz (Editeur), Fritz Sterz (Editeur), Fritz H. Sterz (Editeur), Samue Tisherman (Editeur), Samuel Tisherman (Editeur), Samuel A. Tisherman (Editeur)
Edition Springer, Berlin
 
Langues Anglais
Format d'édition Livre Relié
Sortie 14.07.2005
 
EAN 9780387254029
ISBN 978-0-387-25402-9
Pages 258
Poids 584 g
Illustrations XIV, 258 p.
Thèmes Molecular & Cellular Biology of Critical Care Medicine
Molecular and Cellular Biology
Molecular & Cellular Biology of Critical Care Medicine
Molecular and Cellular Biology
Catégories Sciences naturelles, médecine, informatique, technique > Médecine > Spécialités cliniques

C, Medicine, shock, critical care medicine, critical care, Intensive / Critical Care Medicine, Intensive Care Medicine, cerebral ischemia

Commentaires des clients

Aucune analyse n'a été rédigée sur cet article pour le moment. Sois le premier à donner ton avis et aide les autres utilisateurs à prendre leur décision d'achat.

Écris un commentaire

Super ou nul ? Donne ton propre avis.

Pour les messages à CeDe.ch, veuillez utiliser le formulaire de contact.

Il faut impérativement remplir les champs de saisie marqués d'une *.

En soumettant ce formulaire, tu acceptes notre déclaration de protection des données.